Endotracheal Tube Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Regular Endotracheal Tube, Reinforced Endotracheal Tube, Preformed Endotracheal Tube, Double-Lumen Endotracheal Tube), By Route Type (Orotracheal, Nasotracheal), By Application (Emergency Treatment, Therapy, Others), By End Use (Clinics, Hospitals, Ambulatory Surgical Centers, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 2.78 Billion
CAGR (2026-2031)	6.95%
Fastest Growing Segment	Orotracheal
Largest Market	North America
Market Size (2031)	USD 4.16 Billion

Market Overview

The Global Endotracheal Tube Market is projected to grow from USD 2.78 Billion in 2025 to USD 4.16 Billion by 2031 at a 6.95% CAGR. The global endotracheal tube market comprises flexible catheters inserted into the trachea to maintain a patent airway and facilitate mechanical ventilation during anesthesia or critical care. Growth is primarily driven by the rising volume of surgical procedures requiring general anesthesia and the increasing prevalence of respiratory disorders. According to the American Hospital Association, in 2025, the total number of admissions in all U.S. hospitals reached 34,426,650, indicating a robust baseline of healthcare utilization that sustains demand for airway management devices.

This expansion is further supported by an aging global population susceptible to critical illnesses and advancements in tube materials designed to minimize tissue irritation. However, the market faces a significant challenge regarding the high incidence of ventilator-associated pneumonia and tracheal injuries. These post-intubation complications can lead to extended hospital stays and escalated healthcare costs, potentially impeding broader market adoption in resource-constrained settings.

Key Market Drivers

The increasing prevalence of chronic respiratory diseases and cardiovascular disorders is a primary force propelling the Global Endotracheal Tube Market. As conditions such as chronic obstructive pulmonary disease (COPD) and severe asthma become more widespread, the frequency of hospital admissions requiring mechanical ventilation and airway management has escalated. This trajectory necessitates that healthcare institutions maintain robust inventories of endotracheal tubes to manage acute respiratory failure in intensive care settings. According to the World Health Organization, May 2025, in the 'Chronic respiratory diseases' key facts sheet, there are 81.7 million people living with chronic respiratory diseases in the European Region alone, highlighting the immense patient base susceptible to critical airway interventions. This substantial disease burden directly correlates with sustained procurement orders for both standard and specialty tubes.

Simultaneously, the surging demand for solutions to prevent ventilator-associated pneumonia (VAP) is reshaping product preferences toward technologically advanced designs. VAP remains a critical challenge in ICUs, driving the adoption of tubes equipped with subglottic secretion drainage and antimicrobial coatings to reduce infection risks and associated healthcare costs. According to the National Institutes of Health, February 2025, in the 'Ventilator-Associated Pneumonia in Intensive Care Units' article, VAP rates increased significantly by 111% compared to pre-pandemic levels, underscoring the urgent clinical need for effective preventive devices. Manufacturers are responding to this necessity and the broader need for anesthesia delivery by expanding their critical care portfolios. For instance, according to Teleflex Incorporated, November 2025, in their 'Third Quarter Financial Results', the Anesthesia segment generated $101.4 million in revenue, reflecting the continued robust consumption of airway management solutions in surgical and critical care environments.

Download Free Sample Report

Key Market Challenges

The high incidence of post-intubation complications, particularly tracheal injuries and ventilator-associated adverse events, constitutes a significant restraint on the global endotracheal tube market. These complications necessitate prolonged intensive care stays and complex therapeutic interventions, thereby escalating the operational costs for healthcare providers. When the usage of airway management devices correlates with severe patient outcomes, hospitals face increased liability and financial penalties, which directly impacts their procurement budgets. Consequently, facilities in resource-constrained settings often limit their inventory expansion or delay elective procedures requiring general anesthesia to mitigate these clinical risks, effectively dampening overall market demand.

This challenge is substantiated by recent clinical safety data highlighting the persistence of airway management risks. According to the All India Difficult Airway Association, in 2025, it was reported that approximately 16% of airway-related brain injuries and 4% of fatalities occurred specifically during the post-extubation phase. Such statistics underscore the critical nature of these devices and the severe economic and reputational consequences of failure, which compels healthcare administrators to prioritize risk management expenses over the volume-based procurement of endotracheal tubes.

Key Market Trends

The development of camera-embedded video endotracheal tubes is revolutionizing airway management by enabling continuous visualization of the tracheal structures during and after intubation. These advanced devices integrate high-resolution CMOS sensors directly into the tube's distal tip, allowing clinicians to verify placement and monitor airway patency in real-time without requiring a separate bronchoscope. This innovation significantly enhances patient safety by reducing the risk of esophageal intubation and minimizing trauma during difficult airway procedures, thereby accelerating their adoption in critical care units. This demand for integrated visualization solutions is reflected in recent industry performance; according to Ambu A/S, January 2025, in the 'Interim Report for Q1 2024/25', the Pulmonology segment, which includes single-use visualization devices, achieved an organic revenue growth of 17.7%, underscoring the rapid market shift toward sensor-equipped airway technologies.

Simultaneously, there is a distinct clinical shift towards the use of cuffed endotracheal tubes for pediatric patients, replacing traditional uncuffed designs. Recent anatomical research and updated clinical guidelines advocate for cuffed variants to ensure a better tracheal seal, which optimizes ventilation control and reduces the need for repeated intubations due to air leakage. Manufacturers have responded by utilizing ultra-thin polyurethane cuffs that minimize pressure on the pediatric tracheal mucosa, thereby overcoming historical safety concerns regarding subglottic stenosis. The commercial success of such advanced airway portfolios is evident in broader market results; according to Teleflex Incorporated, February 2025, in the 'Fourth Quarter and Full Year 2024 Financial Results', the company reported total GAAP revenues of $3,047.3 million, highlighting the sustained financial traction of comprehensive anesthesia and airway management product lines in the global healthcare sector.

Segmental Insights

The orotracheal segment represents the fastest growing category in the global endotracheal tube market due to its extensive utilization in emergency medicine and general anesthesia. Clinicians largely prefer this insertion route because it allows for rapid airway establishment with fewer procedural complexities than nasotracheal alternatives. Supportive protocols regarding difficult airway management from entities like the American Society of Anesthesiologists further validate this approach in critical scenarios to minimize patient risk. Consequently, the demand for these devices remains high as healthcare providers prioritize speed and ease of use for effective patient ventilation during surgical and acute interventions.

Regional Insights

North America leads the global endotracheal tube market, primarily driven by the rising prevalence of chronic respiratory diseases and a high volume of surgical procedures requiring general anesthesia. The region benefits from an established healthcare infrastructure and favorable reimbursement policies that facilitate patient access to airway management solutions. Furthermore, the presence of major medical device manufacturers allows for consistent product availability. The U.S. Food and Drug Administration (FDA) supports this growth by enforcing rigorous safety standards, which maintains provider confidence in these essential medical devices.

Recent Developments

• In September 2025, Ambu A/S unveiled the Ambu SureSight Video Laryngoscope, a new addition to its airway management portfolio designed to enhance patient safety during intubation. This system integrates with the company’s existing displaying units and offers features such as dual-view capabilities, allowing clinicians to simultaneously monitor multiple airway devices on a single screen. The launch of this platform aims to streamline workflow in critical care and operating room settings by providing a comprehensive visualization ecosystem that supports efficient and accurate placement of endotracheal tubes in patients with difficult airways.
• In January 2025, 42 Technology launched LARi, an innovative video-capable medical device designed to improve the safety and speed of endotracheal intubation. Unveiled at the CES event, this handheld video stylet allows clinicians to visualize the vocal cords and tracheal opening in real-time while shaping and guiding the endotracheal tube into place. The device is designed to integrate seamlessly into existing anaesthesia workflows as a low-cost, single-use solution, aiming to reduce the risk of failed intubations and airway trauma by providing direct visual feedback during the tube placement process.
• In October 2024, Verathon, a subsidiary of Roper Technologies, announced the commercial launch of the Spectrum QC eco, a single-use video laryngoscope designed with environmental sustainability in mind. This new product features a handle shell made from more than 80% bio-based plastic, significantly reducing the carbon footprint compared to traditional fossil-fuel-based devices while maintaining the clinical performance of the GlideScope portfolio. The launch addresses the growing demand for sustainable medical devices in the airway management sector, supporting hospitals in their efforts to reduce medical waste and environmental impact during intubation procedures.
• In February 2024, N8 Medical announced the publication of a study protocol in the BMJ Open journal regarding the CEASE VAP trial, which evaluates the efficacy of the company’s CeraShield Endotracheal Tube. The research compares this novel device, which features a proprietary ceragenin coating designed to prevent bacterial and fungal biofilm formation, against a standard endotracheal tube with subglottic secretion drainage. This breakthrough research aims to determine if the coated tube can significantly reduce the incidence of ventilator-associated pneumonia (VAP) in critically ill patients, potentially improving clinical outcomes and reducing healthcare costs associated with mechanical ventilation.

Key Market Players

• ANGIPLAST PRIVATE LIMITED
• Stermid Group.
• ICU Medical, Inc.
• Medtronic Inc.
• Van Oostveen Medical B.V.
• Teleflex Incorporated
• Convatec Inc.
• Fuji Systems Corporation
• SEWOON MEDICAL Co., Ltd.
• Mercury Enterprises, Inc.

By Product Type	By Route Type	By Application	By End Use	By Region
Regular Endotracheal Tube Reinforced Endotracheal Tube Preformed Endotracheal Tube Double-Lumen Endotracheal Tube	Orotracheal Nasotracheal	Emergency Treatment Therapy Others	Clinics Hospitals Ambulatory Surgical Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Endotracheal Tube Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Endotracheal Tube Market, By Product Type:

• Regular Endotracheal Tube
• Reinforced Endotracheal Tube
• Preformed Endotracheal Tube
• Double-Lumen Endotracheal Tube

• Endotracheal Tube Market, By Route Type:

• Orotracheal
• Nasotracheal

• Endotracheal Tube Market, By Application:

• Emergency Treatment
• Therapy
• Others

• Endotracheal Tube Market, By End Use:

• Clinics
• Hospitals
• Ambulatory Surgical Centers
• Others

• Endotracheal Tube Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE